Table 4 Characteristics of children with and without clinical tumor lysis syndrome
CTLS | ||||
|---|---|---|---|---|
Yes (n,%) | No (n,%) | P value | ||
Age (year) | n | 13 | 94 | 0.101 |
Min-Max (Median) | 3.52-12.97 (8.38) | 1.7-17.41 (10,06) | ||
Mean±SD | 7.91±3.04 | 9.56±3.81 | ||
Gender | Male | 10 (76.9) | 76 (80.9) | 0.716 |
Female | 3 (23.1) | 18 (19.1) | ||
Histopathological subgroups | Burkitt lymphoma | 12 (92.3) | 68 (72.3) | 0.451 |
Lymphoblastic lymphoma | 1 (7.7) | 18 (19.1) | ||
DLBCL | 0 (0.0) | 5 (5.4) | ||
ALCL | 0 (0.0) | 3 (3.2) | ||
Stage | Stage 2 | 1 (7.6) | 24 (25.6) | 0.090 |
Stage 3 | 6 (46.2) | 54 (57.4) | ||
Stage 4 | 6 (46.2) | 16 (17.0) | ||
LDH level at presentation | n | 13 | 94 | 0.046 |
Min-Max (median) | 71-3790 (1056) | 140-9840 (617.5) | ||
Mean±SD | 1477.69±1084.93 | 984.95±1183.66 | ||
Bone marrow involvement | 4 (30.8) | 8 (8,5) | 0.038 | |
Renal involvement | 0 | 11(11.7) | 0.353 | |